Interleukin-12 in Treating Patients With Multiple Myeloma
NCT00003149
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
NETWORK
Sponsor class
Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL:
recombinant interleukin-12
Sponsor
Eastern Cooperative Oncology Group
Collaborators
[object Object]